Rajender Vemula

发表

Advancement of GyrB inhibitors for treatment of infections caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria.

M. Pucci, S. Stokes, Rajender Vemula, 2020, ACS infectious diseases.

Regioselective Synthesis of a C-4'' Carbamate,C-6'' n-Pr Substituted Cyclitol Analogue of SL0101.

D. Lannigan, G. O'Doherty, Bulan Wu, 2020, Organic letters.

Achmatowicz approach to the asymmetric synthesis of both (+)- and (−)-monanchorin

G. O'Doherty, Bulan Wu, Qi Zhang, 2022, Green Synthesis and Catalysis.

A New, Short, and Stereocontrolled Synthesis of C2-Symmetric 1,2-Diamines.

E. Corey, Rajender Vemula, Nathan C. Wilde, 2017, Organic letters.

Synthesis of the C1–C15 fragment of elaiolide

Rajender Vemula, Gangadhara Rao Yarrapothu, Y. Singh, 2013 .

De Novo Synthesis and Biological Evaluation of C6″-Substituted C4″-Amide Analogues of SL0101

D. Lannigan, G. O'Doherty, Bulan Wu, 2014, Organic letters.

Improving the affinity of SL0101 for RSK using structure-based design.

D. Lannigan, S. Hecht, G. O'Doherty, 2013, ACS medicinal chemistry letters.

An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.

J. Wood, Wanying Zhu, Clinton E. Canal, 2015, ACS chemical neuroscience.

Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modeling.

G. Kellogg, Clinton E. Canal, R. Booth, 2019, Bioorganic & medicinal chemistry.